At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,006 enrolled
Drug / intervention
Olanzapine +2 moredrug
Likely dose
Olanzapine 20mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Metabolic Profile and Anthropometric Changes in Schizophrenia
Central Institute of Psychiatry, Ranchi, India·interventional·Posted Sep 24, 2007·Updated Sep 24, 2007
In Brief
A clinical study evaluating Olanzapine, Risperidone, and 1 other intervention for Metabolic Syndrome and 2 related conditions. Completed, enrolled 2,006 participants across 1 site.
Detailed Summary
"No clinical differences will be found between the three antipsychotics under study - olanzapine, risperidone and haloperidol - on the patients' metabolic profile and weight. "
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetabolic Syndrome, Diabetes, Obesity
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2006
Study CompletionDec 2006
First PostedSep 2007
TodayJul 2026
First PostedSep 24, 2007
Enrollment StartJun 1, 2006
Study CompletionDec 1, 2006
TodayJul 2, 2026
Posted 18.8 years ago
Interventions
Olanzapinedrug
Olanzapine in dose range of 10-20mg
Risperidonedrug
Risperidone 1-6mg
Haloperidoldrug
Haloperidol 10-20mg